Low-Dose Naltrexone for Pruritus in Systemic Sclerosis

Low-Dose Naltrexone for Pruritus in Systemic Sclerosis

Pruritus is a common symptom in systemic sclerosis (SSc), an autoimmune disease which causes fibrosis and vasculopathy in skin, lung, and gastrointestinal tract (GIT). Unfortunately, pruritus has limited treatment options in this disease. Pilot trials of low-dose naltrexone hydrochloride (LDN) for p...

Full description

Bibliographic Details
Main Authors:	Tracy Frech, Kirsten Novak, Monica P. Revelo, Maureen Murtaugh, Boaz Markewitz, Nathan Hatton, Mary Beth Scholand, Edward Frech, David Markewitz, Allen D. Sawitzke
Format:	Article
Language:	English
Published:	Hindawi Limited 2011-01-01
Series:	International Journal of Rheumatology
Online Access:	http://dx.doi.org/10.1155/2011/804296

Similar Items

The Vascular Microenvironment and Systemic Sclerosis
by: Tracy Frech, et al.
Published: (2010-01-01)

The Prevalence and Clinical Correlates of an Auscultatory Gap in Systemic Sclerosis Patients
by: Tracy M. Frech, et al.
Published: (2012-01-01)

Low dose naltrexone in multiple sclerosis: Effects on medication use. A quasi-experimental study.
by: Guttorm Raknes, et al.
Published: (2017-01-01)

Conference Review: Reconstructive and Experimental Archaeology Conference REARC 2012
by: Darrell Markewitz
Published: (2013-02-01)

"But if you don't get any IRON..." Towards an Effective Method for Small Iron Smelting Furnaces
by: Darrell Markewitz
Published: (2012-01-01)

Standardized Reporting of Experimental Iron Smelting - A modest (?) Proposal
by: Darrell Markewitz
Published: (2021-02-01)

Kirsten Adamzik. 2018. Fachsprachen. Die Konstruktion von Welten. Tübingen: Narr/Francke/Attempto. 357 S.
by: Markewitz Friedrich
Published: (2019-12-01)

Vilmos Ágel: Grammatische Textanalyse. Textglieder, Satzglieder, Wortgruppenglieder. Berlin, Boston: De Gruyter. 2017
by: Markewitz Friedrich
Published: (2018-06-01)

Albrecht Greule, Sandra Reimann: Basiswissen Textgrammatik. Tübingen: Narr Francke, Attempto 2015 (UTB 4226)
by: Markewitz Friedrich
Published: (2018-06-01)

Interactions des résidus miniers et du lixiviat d'une couverture de sous-produits de desencrage dans le contexte du controle du drainage minier acide
by: Markewitz, Karine
Published: (2003)

Low-Dose Naltrexone (LDN)—Review of Therapeutic Utilization
by: Karlo Toljan, et al.
Published: (2018-09-01)

The Effects of Low Dose Naltrexone on Opioid Induced Hyperalgesia and Fibromyalgia
by: Daniel Jackson, et al.
Published: (2021-02-01)

Prospective of low dose naltrexone use in treatment of autoimmune pathology and endometriosis
by: O. V. Golianovskyi, et al.
Published: (2020-11-01)

Low Dose Naltrexone - Efficacy and safety of off-label use therapy.
by: Andrzej Stańczak
Published: (2020-01-01)

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients
by: Mitchell R. K. L. Lie, et al.
Published: (2018-03-01)

Open Label Trial of Naltrexone Implants: Measuring Blood Serum Levels of Naltrexone
by: Ross M. Colquhoun
Published: (2013-05-01)

Open Label Trial of Naltrexone Implants: Measuring Blood Serum Levels of Naltrexone
by: Ross M. Colquhoun
Published: (2013-01-01)

Ultra-low dose naltrexone attenuates chronic morphine-induced gliosis in rats
by: Milne Brian, et al.
Published: (2010-04-01)

Low-dose and high-dose naltrexone in opioid dependence syndrome: a three months outcome study
by: Ajeet Sidana, et al.
Published: (2019-06-01)

Naltrexone‐induced drug eruption
by: Johannes Heck, et al.
Published: (2020-10-01)

Clinical Characteristics of Pruritus in Systemic Sclerosis Vary According to the Autoimmune Subtype
by: Greta Gourier, et al.
Published: (2018-06-01)

Intranasal Low-Dose Naltrexone Against Opioid Side Effects: A Preclinical Study
by: Laura Micheli, et al.
Published: (2020-09-01)

Reduced Pro-Inflammatory Cytokines after Eight Weeks of Low-Dose Naltrexone for Fibromyalgia
by: Luke Parkitny, et al.
Published: (2017-04-01)

Eosinophilic Esophagitis in Two Patients with Systemic Sclerosis
by: Tracy M. Frech, et al.
Published: (2016-01-01)

High-dose doxepin for the treatment of chronic, intractable scalp pruritus
by: Stephanie Chan, BS, et al.
Published: (2021-02-01)

Walddynamik in Mischwäldern des Nationalparks Hainich
by: Frech, Annika
Published: (2013)

Defending Carens - a Reply to Hosein : A contribution to the contemporary immigration debate
by: Frech, Johannes
Published: (2014)

Die Meinertsche Spinnmühle in Lugau
by: Frech, Wolfgang
Published: (2018)

Uncovering the drivers of customer engagement behaviours : investigating key mediating mechanisms underlying the link between customer satisfaction and customer engagement behaviours in a higher education context
by: Frech, Bernadette
Published: (2018)

Healthy Behavior Trajectories between Adolescence and Emerging Adulthood
by: Frech, Adrianne
Published: (2009)

Approaches to the Development of a Low-dose Naltrexone Preparation in the Form of a Nasal Spray (Review)
by: Yu. M. Domnina, et al.
Published: (2021-02-01)

Proceedings #47: Low Dose Naltrexone: A Viable Alternative for Long Term Chronic Pain?
by: Victor Rivera, MD, LCDR, USN, MC, et al.
Published: (2019-03-01)

Tropical pruritus
by: Pierre Loulergue, et al.
Published: (2014-07-01)

Chronic pruritus
by: Ana María Villa-Arango, et al.
Published: (2019-04-01)

Pruritus Gravidarum
by: Thappa Devinder Mohan
Published: (1999-01-01)

Pruritus Uremik
by: Sudung O. Pardede
Published: (2016-11-01)

Dyskinesias occur in response to saline and naltrexone alone after priming with combination of dopaminergic agents and naltrexone in the MPTP parkinsonian monkeys
by: Pershia Samadi, et al.
Published: (2005-06-01)

Evaluation of Different Doses of Fentanyl in Controlling Agitation in Acute Opioid Withdrawal Syndrome Induced by Naltrexone Misuse
by: Farzad Gheshlaghi, et al.
Published: (2012-03-01)

The Future of Fossil Fired Power Plants in Germany—A Lifetime Analysis
by: Peter Markewitz, et al.
Published: (2018-06-01)

The Potential Role of Naltrexone in Borderline Personality Disorder
by: Azadeh Moghaddas, et al.
Published: (2017-04-01)